Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06OFD
|
||||
| Former ID |
DIB016889
|
||||
| Drug Name |
BAY-85-8102
|
||||
| Synonyms |
Benzodiazepine receptor agonist (brain disease imaging), University of Sydney; DPA-714-[18F]; F-18 DPA-714; Fluorine-18-DPA-714; Translocator protein-specific ligand (brain disease imaging), University of Sydney; 18F-DPA-714
|
||||
| Indication | Brain diseases [ICD10:G00-G99] | Phase 1 | [522842] | ||
| Company |
University of Sydney
|
||||
| Canonical SMILES |
c1c(nc2n(c1C)nc(c2CC(=O)N(CC)CC)c1ccc(cc1)OCC[18F])C
|
||||
| Target and Pathway | |||||
| Target(s) | Peripheral-type benzodiazepine receptor | Target Info | Agonist | [543743] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| HTLV-I infection | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.